The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia-Reference-Cited by-同舟云学术

The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia

Published:2017-06-20 Issue:9 Volume:31 Page:2000-2005
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rio-Machin A,Gómez-López G,Muñoz J,Garcia-Martinez F,Maiques-Diaz A,Alvarez S,Salgado R N,Shrestha M,Torres-Ruiz R,Haferlach C,Larráyoz M J,Calasanz M J,Fitzgibbon J,Cigudosa J C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017194.pdf

Reference18 articles.

1. Takeda A, Goolsby C, Yaseen NR . NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Cancer Res 2006; 66: 6628–6637.

2. Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C et al. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 2012; 119: 388–398.

3. Liang Y, Franks TM, Marchetto MC, Gage FH, Hetzer MW . Dynamic association of NUP98 with the human genome. PLoS Genet 2013; 9: e1003308.

4. Smith E, Shilatifard A . Enhancer biology and enhanceropathies. Nat Struct Mol Biol 2014; 21: 210–219.

5. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 2010; 8: e1000384.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study;BMC Cancer;2024-08-05

2. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia;Medical Oncology;2024-01-23

3. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression;European Journal of Medical Genetics;2023-12

4. Phase-separating fusion proteins drive cancer by dysregulating transcription through ectopic condensates;2023-09-21

5. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure;Cell Reports;2023-08